# XPANCEO Financial Model

Deep tech startup developing a smart contact lens that delivers augmented/extended reality directly on the eye, replacing all screens.

- Canonical: https://finamodel.com/startups/xpanceo
- Excel download: https://finamodel.com/startup-models/xpanceo.xlsx
- Category: Fintech
- Model type: SaaS ARR / Valuation
- Funding round: Seed
- Funding: $40M
- Founded: 2024
- Geography: Global; key markets cited: USA, South Korea, UK, Germany. [DECK slide 9]
- Customer: B2C

## About the company

XPANCEO is developing a smart contact lens intended to deliver augmented and extended reality directly on the eye. Its long-term vision is a computing platform that replaces conventional screens with a wearable device and associated ecosystem.

The company identifies device sales, advertising, app commissions, maintenance and warranty services, and financial products as potential revenue streams. The concept includes a recurring consumable-lens element alongside hardware, which can make lifetime revenue more important than the first device sale.

The model should forecast unit shipments, device price, replacement-lens subscriptions, hardware and consumable cost, active users, app spend, advertising impressions, and service attachment. Manufacturing capex, R&D, warranty reserves, and platform take rates should be kept separate in a hardware-plus-ecosystem P&L.

## What's included

- 5-year monthly revenue build with stage-appropriate growth assumptions
- Full P&L, headcount plan, and operating-expense schedule
- Cash-flow statement, runway, and burn-rate tracking
- Valuation via exit multiple with a DCF cross-check
- Returns analysis with MOIC and IRR
- Unit economics including CAC, LTV, payback, and cohort retention

## Product & value proposition

XPANCEO's smart contact lens embeds an AR display, solar cells, biosensors, camera, neural interface, adaptive prescription lens, data/power antenna, and batteries into a single contact lens form factor.

Key value props:
- Invisible and weightless - no head-mounted device
- 100% field of view (unlimited FOV for AR content)
- Replaces smartphone, laptop, tablet, TV in one interface
- "SuperVision" features: night vision, zoom, infrared
- Advanced biosensor platform: IOP, dry eye, cortisol, glucose, heart rate, temperature
- Health monitoring and well-being centre
- 20+ patent-pending technologies
- Top-5 optics laboratory (per BCG ranking)

## Market

- AR market (TAM proxy): USD 10B in 2022 → USD 225B in 2030; CAGR 41%
- Combined TAM (medical, well-being, super vision, holographic): $750B
- Worldwide contact lens users by 2033: >250M
- Annual contact lens segment volume: >10B units/year
- Regional contact lens user base by 2033: USA 49M, South Korea 12M, UK 4.4M, Germany 3.5M

## Revenue model

Five stated revenue streams:
1. Selling devices (hardware)
2. Advertising (AR on surfaces)
3. Commissions from third-party apps and content
4. Infrastructure, warranty, maintenance, repairs
5. Financial products, services and payment systems

Per-user annual revenue breakdown implied (at scale):
- Device MSRP: $1,500 (annual replacement lens $50/month × 12 = $600 + $300 hardware = $900 cost, implying consumable model)
- App commission revenue: +$100/year per user
- Ad revenue: +$1,800/year per user (AR on surfaces)

## Traction & metrics

- No revenue traction in deck - company is pre-commercial / R&D stage.
- User projection chart:
  - 2026: 15K users (early adopters)
  - 2027: 30K
  - 2028: 500K
  - 2029: 1M
  - 2030: 2M
  - 2031: 5M (cross-over point to non-CL users)
  - 2032: 10M
- Team: 80% scientists/engineers; 50% PhD; 200+ published articles; co-founder Valentyn Volkov 7,000+ citations
- Founder Roman Axelrod: 3 exits, deals >$5B total
- Competitor Mojo Vision raised $204M, tested complete prototype on a human, then pivoted to microLED

## Unit economics

- COGS (at tens-of-millions units/year scale): $900 per user/year ($50/month × 12 lenses + $300 device component)
- MSRP: $1,500
- Revenue on cost: ×3.4 (implying ~$3,060 total revenue per user including recurring streams)
- Gross / profit margin: 74%
- Additional per-user revenue streams: $100/year (app commissions) + $1,800/year (ads)

Note: the ×3.4 revenue-on-cost metric and 74% margin appear to be blended across all revenue streams at assumed scale, not year-1 economics.

## Competition / moat

Competitors:
- Mojo Vision - raised $204M, pivoted to microLED; validated the category
- Innovega Inc. - iOptik smart contact lens + glasses hybrid
- InWith Corp. - electronic soft contact lens for Metaverse
- SmartLens / Sensimed - medical-only (glaucoma)

vs. AR glasses (implicit competition):
- Bulky, uncool, restrict peripheral vision, need cleaning, distract others

Moat claims:
- 20+ patent-pending technologies
- Top-5 global optics lab (BCG)
- Novel 2D materials (transition metal dichalcogenides), perovskite solar cells, femtosecond laser-based nanoparticles - published in Nature Communications, Nano Letters, PNAS
- Full-stack: optics, AI, novel materials, neural interfacing

## Team & funding ask / use of funds

Team:
- Founder: Roman Axelrod - serial entrepreneur (computer vision, esports, fintech); 3 exits; $5B+ deal experience
- Co-founder: Valentyn Volkov, PhD - nanophotonics expert; 20+ years; 200+ papers; 7,000+ citations

---

## Recommended financial model

- **Archetype + why:** Hardware + platform subscription/ad model. XPANCEO is a device company with layered recurring software/advertising revenue - closest archetype is a consumer hardware + ecosystem model (think iPhone + App Store economics, but with AR ads). Best modelled as a **unit-economics-driven revenue build** combining device sales (one-time or annual consumable), app-commission SaaS-like revenue, and advertising CPM/DAU revenue. A light 3-statement P&L (IS + BS + CF) wraps the top.

- **Forecast horizon & granularity:** 2026–2032 (7 years), annual. Mirrors the deck's own user curve. Pre-launch years (2024–2025) shown as R&D burn only.

- **Key drivers & assumptions:**

| Driver | Value | Source |
| -- | -- | -- |
| Launch year | 2026 | - |
| Users 2026 | 15,000 | - |
| Users 2027 | 30,000 | - |
| Users 2028 | 500,000 | - |
| Users 2029 | 1,000,000 | - |
| Users 2030 | 2,000,000 | - |
| Users 2031 | 5,000,000 | - |
| Users 2032 | 10,000,000 | - |
| Device MSRP | $1,500/user/year | - |
| COGS per user/year (at scale) | $900 | - |
| App commission revenue/user/year | $100 | - |
| Ad revenue/user/year | $1,800 | - |
| Blended profit margin (at scale) | 74% | - |
| Revenue/cost multiple | ×3.4 | - |
| COGS ramp (early years, pre-scale) | Higher, ~$2,000–$3,000/unit | early production runs are more expensive before volume discounts; deck's $900 is stated at "tens of millions of lenses/year" |
| Ad revenue ramp-in | 0% at launch → 100% by 2029 | ad inventory requires scale; unlikely from day 1 |
| App commission ramp-in | 25% in 2026 → 100% by 2028 | app ecosystem needs time to build |
| R&D opex (pre-launch) | $20–50M/year burn; no data in deck |
| G&A + Sales & Marketing as % of revenue | ~20–30% in early years, declining to ~15% at scale; benchmarked against hardware/platform cos |
| Annual churn / replacement rate | ~10–15%/year; contact lenses are consumables with natural cadence but smart lens may have longer commitment |
| TAM penetration ceiling | ~4% of 250M CL users by 2032 (=10M) | - |

- **Scenarios (Base / Bull / Bear - which variables flex):**
  - Base: Deck's stated user curve; full MSRP; ad revenue starts 2028
  - Bull: User adoption 1.5× base; ad ARPU $2,500/year; faster crossover to non-CL users
  - Bear: 2-year delay to product-market fit; users 50% of base; no ad revenue until 2030; COGS 20% higher than stated

- **Required sheets / outputs:**
  1. Assumptions (all drivers above, toggleable)
  2. User Growth Model (annual cohorts, new users, cumulative active users)
  3. Revenue Build (device revenue + app commissions + ad revenue + services; by stream)
  4. COGS & Gross Margin (scale curve on unit cost)
  5. Opex (R&D, S&M, G&A - pre-launch heavy)
  6. Income Statement (P&L through EBITDA)
  7. Simplified Balance Sheet + Cash Flow (to show funding need and runway)
  8. Scenario Toggle (Base / Bull / Bear)
  9. Dashboard (KPI summary: users, revenue, EBITDA, cash runway)

## Frequently asked questions

### Is the XPANCEO financial model free?

Yes. The XPANCEO model is a free Excel download with live formulas.

### Can I change the assumptions?

Yes. The workbook is editable and its live formulas recalculate when assumptions change.